FLGC Logo

Flora Growth Corp. (FLGC) 

NASDAQ$0.655-0.02 (-2.97%)
Market Cap
$13.1M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
143 of 919
Rank in Industry
6 of 56

FLGC Insider Trading Activity

FLGC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,030,7574100
Sells
$000

Related Transactions

Starke CliffordCEO3$1.01M0$0$1.01M
Wolkin Harolddirector1$24,2550$0$24,255

About Flora Growth Corp.

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.

Insider Activity of Flora Growth Corp.

Over the last 12 months, insiders at Flora Growth Corp. have bought $1.03M and sold $0 worth of Flora Growth Corp. stock.

On average, over the past 5 years, insiders at Flora Growth Corp. have bought $1.03M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Starke Clifford (CEO) — $1.01M. Wolkin Harold (director) — $24,255.

The last purchase of 6,795 shares for transaction amount of $6,455 was made by Starke Clifford (CEO) on 2024‑09‑13.

List of Insider Buy and Sell Transactions, Flora Growth Corp.

2024-09-13PurchaseStarke CliffordCEO
6,795
0.0278%
$0.95$6,455+14.67%
2024-09-06PurchaseWolkin Harolddirector
25,000
0.1043%
$0.97$24,255+6.92%
2024-09-05PurchaseStarke CliffordCEO
51
0.0002%
$0.95$48+10.98%
2024-04-08PurchaseStarke CliffordCEO
526,315
4.2996%
$1.90$999,999-51.54%
Total: 4
*Gray background shows transactions not older than one year

FLGC Institutional Investors: Active Positions

Increased Positions11+40.74%199,792+48.98%
Decreased Positions10-37.04%57,446-14.08%
New Positions8New148,979New
Sold Out Positions6Sold Out41,272Sold Out
Total Postitions28+3.7%550,213+34.9%

FLGC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Geode Capital Management, Llc$81.000.69%130,934+24,713+23.27%2024-12-31
Renaissance Technologies Llc$71.000.61%115,013-16,130-12.3%2024-12-31
Vanguard Group Inc$55.000.47%88,78000%2024-12-31
Advisorshares Investments Llc$44.000.37%70,420+70,420New2024-12-31
Virtu Financial Llc$26.000.22%41,507+41,507New2024-12-31
State Street Corp$23.000.19%36,600+21,100+136.13%2024-12-31
Hrt Financial Lp$14.000.12%22,913+22,913New2024-12-31
Northern Trust Corp$10.000.09%16,41500%2024-12-31
Ubs Group Ag$8.000.07%13,125+13,125New2024-12-31
Morgan Stanley$7.000.06%11,776+5,000+73.79%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.